BioPharma Product Testing Articles & Whitepapers

Articles & Whitepapers

Clinical Use of Bacteriophage Therapy

Recommendations and considerations for bacteriophage therapy usage in clinical setting. European Pharmaceutical Review, June 2023

Outsourcing Formulation Development

SPECIAL FEATURE – : Putting Customers First Drug Development & Delivery, June 2023; Contributing Author: Joe Page, President, Eurofins BioPharma Product Testing San Diego

Investing in the Future of Biopharmaceuticals

Investing in the Future of Biopharmaceuticals - In San Diego, CA, Eurofins BioPharma Product Testing Offers a Complete Range of Services. American Pharmaceutical Review, May/June 2023

BioPhorum Raw Materials

BioPhorum Raw Materials: A proposal to align release standards for endonucleases used in nucleic acid removal ©BioPhorum Operations Group Ltd, May 2023; Contributing Author: Andrew Schaefer, Manager - Analytical Method Development & Validation

Contract Testing Services for Manufacturing

Contract Testing Services Solidify Their Place in the Manufacturing Value Chain; Pharmaceutical Technology, April 2023, pages 42-44; Interviewee: Stanley Prince, Director of Biosafety & Cell/Gene Therapy Strategy

A Difficult Balance Between Drug and Device

Combination Products: A Difficult Balance Between Drug and Device European Biopharmaceutical Review, January 2023, pages 42-45; © Samedan Ltd; Author: Paolo Pescio, Senior Scientific Director

Complex Workflows Require Robust Bioassays

Complex Analytical Workflows Increasingly Require Robust Bioassays; BioPharm International, January 2023; Contributing Author: Weihong Wang, PhD, Director of Technology Development

ATMP and Cell and Gene Therapy

ATMP and Cell and Gene Therapy Testing Services for the Global Market; American Pharmaceutical Review, November/December 2022

Whole Genome Sequencing of Biotherapeutics

Whole genome sequencing and analysis of live biotherapeutic products; European Pharmaceutical Review, Volume 27, Issue 06; Authors: Michael Timm, Director of Sales and Business Development Snehit Satish Mhatre, Senior Scientific Director

Cell & Gene Therapy Critical Material

Cell and Gene Therapy Critical Starting Material - Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply ©BioPhorum Operations Group Ltd, May 2022; Contributing Author: Andrew Schaefer, Manager - Analytical Method Development & Validation

Quality Control Potency Bioassays Challenges

Challenges of quality control potency bioassays; European Pharmaceutical Review, Volume 27, Issue 03; Authors: Dr. Giulia Mancini, Lab Manager of Bioassay Testing; Dr. Alexander Knorre, Senior Scientific Director Biologics & Bioassays

Facility Expands to Offer New Capabilities

Growing to Serve: Eurofins' Portage, Michigan, Facility Expands to Offer New Capabilities and Services; American Pharmaceutical Review, May/June 2022

Gene Editing & Stem Cell Therapy

Combining Gene Editing and Haematopoietic Stem Cells Gene Therapy Toward Clinical Translation; European Biopharmaceutical Review July 2022; Authors: Marian McKee, PhD, Giulia Rovaris, Claudia Benati, Giulia Mancini, PhD

Facility Expands to Offer New Capabilities

Growing to Serve: Eurofins' Portage, Michigan, Facility Expands to Offer New Capabilities and Services; American Pharmaceutical Review, May/June 2022

Automation Reduces Aseptic Contamination Risk

Automating Aseptic Processing Reduces Contamination Risk; Pharmaceutical Technology, June 2022; Interviewee: Kenneth Laderman, PhD, Manufacturing Director

Mycoplasma Testing in an Ever-Changing World

Mycoplasma Testing in an Ever-Changing World; American Pharmaceutical Review, March 2022; Authors: Christopher C. Smith, Manager Mycoplasma Services, Jonathan M. Demick, Ph.D., Principal Scientist

Container Closure Integrity Testing for Drugs

Pressure Decay: The Container Closure Integrity Testing for Biologic Drugs This article is taken from European Biopharmaceutical Review April 2022; © Samedan Ltd; Author: Salvatore Savino, Ph.D., Package Testing Laboratory Manager

An Interview with Kenneth Laderman

Ph.D. American Pharmaceutical Review, January/February 2022; Interviewee: Kenneth Laderman, Ph.D., Director of Manufacturing

COVID-19 Tests CDMOs' Adaptability

Adaptability of CDMOs Sorely Tested by COVID-19; Genetic Engineering & Biotechnology News, June 2021; Interviewee: Michael J. McDowell, Executive Vice President, Business Development and Project Management

QC Challenges for Adenovirus & RNA Vaccines

The challenge of quality control for adenovirus and RNA-based vaccines; European Pharmaceutical Review Issue 2 2021; Authors: Claudia Benati, Senior Scientific Director; Dr. Anke McCartney, Global Key Account Manager

CAR T, Allogenic, and CAR NK

Autologous, Allogenic CAR T, and the New Frontiers of CAR NK Immunotherapy Products; European Biopharmaceutical Review April 2021; Authors: Claudia Benati, Giulia Mancini, Stanley Prince, Dr. Marian McKee, Frederic Girard

Safety Testing for C&G Therapy Products

European Biopharmaceutical Review January 2021; Authors Claudia Benati, Senior Scientific Director Liesbeth Hameetman, Head of Microbial Safety Department Luca Benedan, Project Leader Giulia Rovaris, Project Leader Mary Davd, Senior Scientist Dr. Jonathan Demick, Principal Scientist

Subscribe to Newsletter

Back to Resources, News & Events